# EDGAR Filing Document

**Accession Number:** 0001274413
**File Stem:** 0001104659-25-076201
**Filing Date:** 2025-8
**Character Count:** 37328
**Document Hash:** e0d848178dd92d57502c17ae1f2557b0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-076201.hdr.sgml**: 20250811

**ACCESSION NUMBER**: 0001104659-25-076201

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250811

**EFFECTIVENESS DATE**: 20250811

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SECTORAL ASSET MANAGEMENT INC
- **CENTRAL INDEX KEY:** 0001274413

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A8

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-10653
- **FILM NUMBER:** 251202708

**BUSINESS ADDRESS:**
- **STREET 1:** 1010 SHERBROOKE ST., WEST
- **STREET 2:** SUITE 1610
- **CITY:** MONTREAL
- **STATE:** A8
- **ZIP:** H3A 2R7
- **BUSINESS PHONE:** 514 849 8777

**MAIL ADDRESS:**
- **STREET 1:** 1010 SHERBROOKE ST., WEST
- **STREET 2:** SUITE 1610
- **CITY:** MONTREAL
- **STATE:** A8
- **ZIP:** H3A 2R7

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001274413

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** SECTORAL ASSET MANAGEMENT INC

**Address:** 1010 SHERBROOKE ST., WEST, MONTREAL, A8 H3A 2R7

**Telephone number:** 514-849-8777

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-10653

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 254900KAKORD58ODPG76

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                      | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Jazz Pharmaceuticals plc            | G50871105 | 07/25/2024     | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           2500 |                0 | FOR         |                                     2500 | FOR                         |  |
| Jazz Pharmaceuticals plc            | G50871105 | 07/25/2024     | To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of Jazz Pharmaceuticals plc's named executive officers.                                                                               | SECTION 14A SAY-ON-PAY VOTES |           2500 |                0 | ONE YEAR    |                                     2500 | FOR                         |  |
| Roivant Sciences Ltd.               | G76279101 | 09/10/2024     | To cast a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          34500 |                0 | FOR         |                                    34500 | FOR                         |  |
| Roivant Sciences Ltd.               | G76279101 | 09/10/2024     | To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          34500 |                0 | ONE YEAR    |                                    34500 | FOR                         |  |
| Medtronic Plc                       | G5960L103 | 10/17/2024     | Approving, on an advisory basis, the Company's executive compensation;                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          29350 |                0 | FOR         |                                    29350 | FOR                         |  |
| Viatris Inc.                        | 92556V106 | 12/06/2024     | Approval of, on a non-binding advisory basis, the 2023 compensation of the named executive officers of the Company.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          19500 |                0 | AGAINST     |                                    19500 | AGAINST                     |  |
| Johnson  Johnson                    | 478160104 | 04/24/2025     | Advisory Vote to Approve Named Executive Officer Compensation                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          17800 |                0 | FOR         |                                    17800 | FOR                         |  |
| Pfizer Inc.                         | 717081103 | 04/24/2025     | 2025 advisory approval of executive compensation                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          59650 |                0 | AGAINST     |                                    59650 | AGAINST                     |  |
| Abbott Laboratories                 | 002824100 | 04/25/2025     | Say on Pay - An Advisory Vote on the Approval of Executive Compensation                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          24398 |                0 | FOR         |                                    24398 | FOR                         |  |
| Moderna, Inc.                       | 60770K107 | 04/30/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |           4350 |                0 | AGAINST     |                                     4350 | AGAINST                     |  |
| Boston Scientific Corporation       | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          26926 |                0 | FOR         |                                    26926 | FOR                         |  |
| Intuitive Surgical, Inc.            | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |           4750 |                0 | FOR         |                                     4750 | FOR                         |  |
| Eli Lilly and Company               | 532457108 | 05/05/2025     | Approval, on an advisory basis, of the compensation paid to the company's named executive officers.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           9716 |                0 | FOR         |                                     9716 | FOR                         |  |
| Bristol-Myers Squibb Company        | 110122108 | 05/06/2025     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          19500 |                0 | FOR         |                                    19500 | FOR                         |  |
| Danaher Corporation                 | 235851102 | 05/06/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          10575 |                0 | FOR         |                                    10575 | FOR                         |  |
| Gilead Sciences, Inc.               | 375558103 | 05/07/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          27780 |                0 | FOR         |                                    27780 | FOR                         |  |
| Alnylam Pharmaceuticals, Inc.       | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           4050 |                0 | FOR         |                                     4050 | FOR                         |  |
| DexCom, Inc.                        | 252131107 | 05/08/2025     | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          15000 |                0 | FOR         |                                    15000 | FOR                         |  |
| Edwards Lifesciences Corporation    | 28176E108 | 05/08/2025     | Advisory Vote to Approve Named Executive Officer Compensation                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |           6000 |                0 | FOR         |                                     6000 | FOR                         |  |
| Stryker Corporation                 | 863667101 | 05/08/2025     | Advisory Vote to Approve Named Executive Officer Compensation.                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           6100 |                0 | FOR         |                                     6100 | FOR                         |  |
| AbbVie Inc.                         | 00287Y109 | 05/09/2025     | Say on Pay - An advisory vote on the approval of executive compensation                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          16800 |                0 | FOR         |                                    16800 | FOR                         |  |
| Royalty Pharma Plc                  | G7709Q104 | 05/12/2025     | A non-binding advisory vote to approve executive compensation that may become payable in connection with the transaction contemplated by the Membership Interest Purchase Agreement.                                                                 | SECTION 14A SAY-ON-PAY VOTES |           7200 |                0 | FOR         |                                     7200 | FOR                         |  |
| Royalty Pharma Plc                  | G7709Q104 | 05/12/2025     | A non-binding advisory vote to approve executive compensation.                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           7200 |                0 | FOR         |                                     7200 | FOR                         |  |
| Cytokinetics, Incorporated          | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          15695 |                0 | FOR         |                                    15695 | FOR                         |  |
| Elevance Health, Inc.               | 036752103 | 05/14/2025     | Advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           1500 |                0 | FOR         |                                     1500 | FOR                         |  |
| SpringWorks Therapeutics, Inc.      | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          23415 |                0 | FOR         |                                    23415 | FOR                         |  |
| Vera Therapeutics, Inc.             | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          26620 |                0 | FOR         |                                    26620 | FOR                         |  |
| Vera Therapeutics, Inc.             | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          26620 |                0 | ONE YEAR    |                                    26620 | FOR                         |  |
| Vertex Pharmaceuticals Incorporated | 92532F100 | 05/14/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           3670 |                0 | FOR         |                                     3670 | FOR                         |  |
| Insmed Incorporated                 | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          11971 |                0 | FOR         |                                    11971 | FOR                         |  |
| Medpace Holdings, Inc.              | 58506Q109 | 05/16/2025     | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |            415 |                0 | FOR         |                                      415 | FOR                         |  |
| BioMarin Pharmaceutical Inc.        | 09061G101 | 05/20/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          20800 |                0 | FOR         |                                    20800 | FOR                         |  |
| BeiGene Ltd.                        | 07725L102 | 05/21/2025     | THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           2285 |                0 | AGAINST     |                                     2285 | AGAINST                     |  |
| Illumina, Inc.                      | 452327109 | 05/21/2025     | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |           2882 |                0 | FOR         |                                     2882 | FOR                         |  |
| Neurocrine Biosciences, Inc.        | 64125C109 | 05/21/2025     | Advisory vote on the compensation paid to the Company's named executive officers;                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |           2300 |                0 | FOR         |                                     2300 | FOR                         |  |
| Thermo Fisher Scientific Inc.       | 883556102 | 05/21/2025     | An advisory vote to approve named executive officer compensation.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |           3250 |                0 | AGAINST     |                                     3250 | AGAINST                     |  |
| Amgen Inc.                          | 031162100 | 05/23/2025     | Advisory vote to approve our executive compensation.                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |           8650 |                0 | FOR         |                                     8650 | FOR                         |  |
| Merck  Co., Inc.                    | 58933Y105 | 05/27/2025     | Non-binding advisory vote to approve the compensation of our named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          38500 |                0 | FOR         |                                    38500 | FOR                         |  |
| UnitedHealth Group Incorporated     | 91324P102 | 06/02/2025     | Advisory approval of the Company's executive compensation.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          12895 |                0 | AGAINST     |                                    12895 | AGAINST                     |  |
| Cogent Biosciences, Inc.            | 19240Q201 | 06/04/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          71400 |                0 | FOR         |                                    71400 | FOR                         |  |
| Amicus Therapeutics, Inc.           | 03152W109 | 06/05/2025     | Approval, on an advisory basis, the Company's executive compensation.                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          96820 |                0 | FOR         |                                    96820 | FOR                         |  |
| CRISPR Therapeutics AG              | H17182108 | 06/05/2025     | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |           2000 |                0 | AGAINST     |                                     2000 | AGAINST                     |  |
| Ionis Pharmaceuticals, Inc.         | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           7200 |                0 | FOR         |                                     7200 | FOR                         |  |
| MoonLake Immunotherapeutics         | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          13687 |                0 | FOR         |                                    13687 | FOR                         |  |
| Axsome Therapeutics, Inc.           | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |            820 |                0 | FOR         |                                      820 | FOR                         |  |
| Arcus Biosciences, Inc.             | 03969F109 | 06/10/2025     | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          21000 |                0 | FOR         |                                    21000 | FOR                         |  |
| Clover Health Investments, Corp.    | 18914F103 | 06/10/2025     | Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2024.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         183000 |                0 | FOR         |                                   183000 | FOR                         |  |
| Incyte Corporation                  | 45337C102 | 06/10/2025     | Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           4700 |                0 | FOR         |                                     4700 | FOR                         |  |
| RadNet, Inc.                        | 750491102 | 06/10/2025     | An advisory vote to approve the compensation of the Company's Named Executive Officers.                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          20000 |                0 | FOR         |                                    20000 | FOR                         |  |
| Crinetics Pharmaceuticals, Inc.     | 22663K107 | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;             | SECTION 14A SAY-ON-PAY VOTES |           4400 |                0 | FOR         |                                     4400 | FOR                         |  |
| Trevi Therapeutics, Inc.            | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          96099 |                0 | FOR         |                                    96099 | FOR                         |  |
| Trevi Therapeutics, Inc.            | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to our named executive officers.                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          96099 |                0 | ONE YEAR    |                                    96099 | FOR                         |  |
| uniQure N.V.                        | N90064101 | 06/11/2025     | Approval, on an advisory basis, of the compensation of the named executive officers of the Company.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          50400 |                0 | FOR         |                                    50400 | FOR                         |  |
| Summit Therapeutics Inc.            | 86627T108 | 06/12/2025     | Approval, by a non-binding advisory vote, of the compensation of our named executive officers.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          56500 |                0 | FOR         |                                    56500 | FOR                         |  |
| Tarsus Pharmaceuticals, Inc.        | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          16420 |                0 | FOR         |                                    16420 | FOR                         |  |
| Tarsus Pharmaceuticals, Inc.        | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.                                     | SECTION 14A SAY-ON-PAY VOTES |          16420 |                0 | ONE YEAR    |                                    16420 | FOR                         |  |
| Vaxcyte, Inc.                       | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          19100 |                0 | AGAINST     |                                    19100 | AGAINST                     |  |
| Regeneron Pharmaceuticals, Inc.     | 75886F107 | 06/13/2025     | Proposal to approve, on an advisory basis, executive compensation.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           2163 |                0 | FOR         |                                     2163 | FOR                         |  |
| Biogen Inc.                         | 09062X103 | 06/17/2025     | Say on Pay - To hold an advisory vote on executive compensation.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |           2220 |                0 | AGAINST     |                                     2220 | AGAINST                     |  |
| PTC Therapeutics, Inc.              | 69366J200 | 06/17/2025     | Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |           6650 |                0 | FOR         |                                     6650 | FOR                         |  |
| Blueprint Medicines Corporation     | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          10820 |                0 | FOR         |                                    10820 | FOR                         |  |
| Recursion Pharmaceuticals, Inc.     | 75629V104 | 06/18/2025     | Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |           9100 |                0 | FOR         |                                     9100 | FOR                         |  |
| Zai Lab Limited                     | G9887T116 | 06/18/2025     | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         198000 |                0 | FOR         |                                   198000 | FOR                         |  |
| Zai Lab Limited                     | 98887Q104 | 06/18/2025     | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          11200 |                0 | FOR         |                                    11200 | FOR                         |  |
| BridgeBio Pharma, Inc.              | 10806X102 | 06/20/2025     | To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          12500 |                0 | AGAINST     |                                    12500 | AGAINST                     |  |
| Madrigal Pharmaceuticals, Inc.      | 558868105 | 06/20/2025     | Advisory vote to approve executive compensation                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |            570 |                0 | FOR         |                                      570 | FOR                         |  |
| Madrigal Pharmaceuticals, Inc.      | 558868105 | 06/20/2025     | Advisory vote to approve the frequency of future advisory votes to approve executive compensation                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |            570 |                0 | ONE YEAR    |                                      570 | FOR                         |  |
| Structure Therapeutics Inc.         | 86366E106 | 06/23/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          31250 |                0 | FOR         |                                    31250 | FOR                         |  |
| Structure Therapeutics Inc.         | 86366E106 | 06/23/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          31250 |                0 | ONE YEAR    |                                    31250 | FOR                         |  |
| Phreesia, Inc.                      | 71944F106 | 06/25/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          34000 |                0 | FOR         |                                    34000 | FOR                         |  |
| Revolution Medicines, Inc.          | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). | SECTION 14A SAY-ON-PAY VOTES |           4900 |                0 | FOR         |                                     4900 | FOR                         |  |
| United Therapeutics Corporation     | 91307C102 | 06/26/2025     | Advisory resolution to approve executive compensation.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |            595 |                0 | FOR         |                                      595 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** SECTORAL ASSET MANAGEMENT INC

**By (Signature):** Marina Lalakin

**By (Printed Signature):** Marina Lalakin

**By (Title):** Chief Compliance Officer

**Date:** 08/08/2025